Stimulation of central A1 adenosine receptors suppresses seizure and neuropathology in a soman nerve agent seizure rat model

References

• Anderson R, Sheehan MJ, Strong P. (1994). Characterization of the adenosine receptors mediating hypothermia in the conscious mouse. Br J Pharmacol 113:1386–90
   PubMed Web of Science ®Google Scholar
• Basheer R, Strecker RE, Thakkar MM, Mccarley RW. (2004). Adenosine and sleep-wake regulation. Prog Neurobiol 73:379–96
   PubMed Web of Science ®Google Scholar
• Benington JH, Kodali SK, Heller HC. (1995). Stimulation of A1 adenosine receptors mimics the electroencephalographic effects of sleep deprivation. Brain Res 692:79–85
   PubMed Web of Science ®Google Scholar
• Biaggioni I. (1992). Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension 20:457–65
   PubMed Web of Science ®Google Scholar
• Bjorness TE, Greene RW. (2009). Adenosine and sleep. Curr Neuropharmacol 7:238–45
   PubMed Web of Science ®Google Scholar
• Bowen SE, Balster RL. (1997). A comparison of the acute behavioral effects of inhaled amyl, ethyl, and butyl acetate in mice. Fundam Appl Toxicol 35:189–96
   PubMedGoogle Scholar
• Bueters TJ, Groen B, Danhof M, et al. (2002). Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication. Arch Toxicol 76:650–6
   PubMed Web of Science ®Google Scholar
• Bueters TJ, Joosen MJ, Van Helden HP, et al. (2003). Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin. J Pharmacol Exp Ther 304:1307–13
   PubMedGoogle Scholar
• Compton JR. (2004). Adenosine receptor agonist Pd 81 723 protects against seizure/status epilepticus and neuropathology following organophosphate exposure. Published by WRAIR and available through DTIC. Silver Spring (MD): Walter Reed Army Institute of Research
   Google Scholar
• Cunha RA. (2005). Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal 1:111–34
   PubMedGoogle Scholar
• D’ambrosio R, Eastman CL, Darvas F, et al. (2013). Mild passive focal cooling prevents epileptic seizures after head injury in rats. Ann Neurol 73:199–209
   PubMedGoogle Scholar
• Dixon AK, Gubitz AK, Sirinathsinghji DJ, et al. (1996). Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461–8
   PubMed Web of Science ®Google Scholar
• Dunwiddie TV, Masino SA. (2001). The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31–55
   PubMed Web of Science ®Google Scholar
• El-Etri MM, Nickell WT, Ennis M, et al. (1992). Brain norepinephrine reductions in soman-intoxicated rats: association with convulsions and AChE inhibition, time course, and relation to other monoamines. Exp Neurol 118:153–63
   PubMed Web of Science ®Google Scholar
• Fosbraey P, Wetherell JR, French MC. (1990). Neurotransmitter changes in guinea-pig brain regions following soman intoxication. J Neurochem 54:72–9
   PubMed Web of Science ®Google Scholar
• Geeraerts T, Vigue B. (2009). Cellular metabolism, temperature and brain injury. Ann Fr Anesth Reanim 28:339–44
   PubMedGoogle Scholar
• Gouder N, Fritschy JM, Boison D. (2003). Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44:877–85
   PubMed Web of Science ®Google Scholar
• Haas HL, Selbach O. (2000). Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 362:375–81
   PubMed Web of Science ®Google Scholar
• Harrison PK, Bueters TJH, Ijzerman AP, et al. (2003). Partial adenosine A1 receptor agonists inhibit sarin-induced epileptiform activity in the hippocampal slice. Eur J Pharmacol 471:97–104
   PubMed Web of Science ®Google Scholar
• Huber A, Guttinger M, Mohler H, Boison D. (2002). Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci Lett 329:289–92
   PubMedGoogle Scholar
• Joosen MA, Bueters TH, Helden HM. (2004). Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning. Arch Toxicol 78:34–9
   PubMed Web of Science ®Google Scholar
• Joosen MJ, Van Helden HP. (2007). Correlations between acetylcholinesterase inhibition, acetylcholine levels and EEG changes during perfusion with neostigmine and N6-cyclopentyladenosine in rat brain. Eur J Pharmacol 555:122–8
   PubMedGoogle Scholar
• Lallement G, Carpentier P, Collet A, et al. (1991). Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res 563:234–40
   PubMed Web of Science ®Google Scholar
• Lin JS, Anaclet C, Sergeeva OA, Haas HL. (2011). The waking brain: an update. Cell Mol Life Sci 68:2499–512
   PubMedGoogle Scholar
• Liu Z, Gatt A, Mikati M, Holmes GL. (1993). Effect of temperature on kainic acid-induced seizures. Brain Res 631:51–8
   PubMedGoogle Scholar
• Lynge J, Hellsten Y. (2000). Distribution of adenosine A1, A2A and A2B receptors in human skeletal muscle. Acta Physiol Scand 169:283–90
   PubMedGoogle Scholar
• Malva JO, Silva AP, Cunha RA. (2003). Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors. Neurochem Res 28:1501–15
   PubMed Web of Science ®Google Scholar
• Mcdonough JH Jr, Dochterman LW, Smith CD, Shih TM. (1995). Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 16:123–32
   PubMed Web of Science ®Google Scholar
• Mcdonough JH, Shih T-M. (1997). Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 21:559–79
   PubMed Web of Science ®Google Scholar
• Mcintyre LA, Fergusson DA, Hébert PC, et al. (2003). Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA 289:2992–9
   PubMed Web of Science ®Google Scholar
• Mesulam MM, Mufson EJ, Levey AI, Wainer BH. (1983). Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214:170–97
   PubMed Web of Science ®Google Scholar
• Methippara MM, Kumar S, Alam MN, et al. (2005). Effects on sleep of microdialysis of adenosine A1 and A2a receptor analogs into the lateral preoptic area of rats. Am J Physiol Regul Integr Comp Physiol 289:R1715–23
   Google Scholar
• O’donnell JC, Acon-Chen C, Mcdonough JH, Shih TM. (2010). Comparison of extracellular striatal acetylcholine and brain seizure activity following acute exposure to the nerve agents cyclosarin and tabun in freely moving guinea pigs. Toxicol Mech Methods 20:600–8
   PubMed Web of Science ®Google Scholar
• O’donnell JC, Mcdonough JH, Shih TM. (2011). In vivo microdialysis and electroencephalographic activity in freely moving guinea pigs exposed to organophosphorus nerve agents sarin and VX: analysis of acetylcholine and glutamate. Arch Toxicol 85:1607–16
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. (2009). The rat brain in stereotaxic coordinates: compact. 6th ed. San Diego (CA): Elsevier, Academic Press
   Google Scholar
• Peterson K, Carson S, Carney N. (2008). Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma 25:62–71
   PubMed Web of Science ®Google Scholar
• Ribeiro JA, Sebastiao AM, De Mendonca A. (2002). Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68:377–92
   PubMed Web of Science ®Google Scholar
• Schindler CW, Karcz-Kubicha M, Thorndike EB, et al. (2005). Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Br J Pharmacol 144:642–50
   PubMed Web of Science ®Google Scholar
• Schubert P, Ogata T, Marchini C, et al. (1997). Protective mechanisms of adenosine in neurons and glial cells. Ann NY Acad Sci 825:1–10
   PubMed Web of Science ®Google Scholar
• Schwartz BG, Kloner RA, Thomas JL, et al. (2012). Therapeutic hypothermia for acute myocardial infarction and cardiac arrest. Am J Cardiol 110:461–6
   PubMed Web of Science ®Google Scholar
• Semba K. (2000). Multiple output pathways of the basal forebrain: organization, chemical heterogeneity, and roles in vigilance. Behav Brain Res 115:117–41
   PubMed Web of Science ®Google Scholar
• Shih TM. (1982). Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain. Psychopharmacology (Berlin) 78:170–5
   PubMed Web of Science ®Google Scholar
• Shih TM. (1990). Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res 7:105–16
   PubMed Web of Science ®Google Scholar
• Shih TM, Duniho SM, Mcdonough JH. (2003). Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 188:69–80
   PubMed Web of Science ®Google Scholar
• Shih TM, Hulet SW, Mcdonough JH. (2006). The effects of repeated low-dose sarin exposure. Toxicol Appl Pharmacol 215:119–34
   PubMed Web of Science ®Google Scholar
• Shih TM, Koviak TA, Capacio BR. (1991). Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci Biobehav Rev 15:349–62
   PubMed Web of Science ®Google Scholar
• Sperlagh B, Vizi ES. (2011). The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects. Curr Top Med Chem 11:1034–46
   PubMed Web of Science ®Google Scholar
• St Hilaire C, Carroll SH, Chen H, Ravid K. (2009). Mechanisms of induction of adenosine receptor genes and its functional significance. J Cell Physiol 218:35–44
   PubMedGoogle Scholar
• Strecker RE, Morairty S, Thakkar MM, et al. (2000). Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav Brain Res 115:183–204
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Hall H, Sedvall G, Fredholm BB. (1997). Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 27:322–35
   PubMed Web of Science ®Google Scholar
• Thakkar MM, Delgiacco RA, Strecker RE, Mccarley RW. (2003). Adenosinergic inhibition of basal forebrain wakefulness-active neurons: a simultaneous unit recording and microdialysis study in freely behaving cats. Neuroscience 122:1107–13
   PubMedGoogle Scholar
• Tuovinen K. (2004). Organophosphate-induced convulsions and prevention of neuropathological damages. Toxicology 196:31–9
   PubMed Web of Science ®Google Scholar
• Tupone D, Madden CJ, Morrison SF. (2013). Central activation of the A1 Adenosine Receptor (A1AR) induces a hypothermic, torpor-like state in the rat. J Neurosci 33:14512–25
   PubMedGoogle Scholar
• Van Helden HP, Groen B, Moor E, et al. (1998). New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release. Drug Chem Toxicol 21:171–81
   PubMed Web of Science ®Google Scholar
• Wade JV, Samson FE, Nelson SR, Pazdernik TL. (1987). Changes in extracellular amino acids during soman- and kainic acid-induced seizures. J Neurochem 49:645–50
   PubMedGoogle Scholar
• Wardas J. (2002). Neuroprotective role of adenosine in the CNS. Pol J Pharmacol 54:313–26
   PubMedGoogle Scholar
• Yildirim M, Marangoz C. (2007). Anticonvulsant effects of focal and intracerebroventricular adenosine on penicillin-induced epileptiform activity in rats. Brain Res 1127:193–200
   PubMed Web of Science ®Google Scholar
• Young D, Dragunow M. (1994). Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 58:245–61
   PubMed Web of Science ®Google Scholar
• Youssef AF, Santi BW. (1997). Simple neurobehavioral functional observational battery and objective gait analysis validation by the use of acrylamide and methanol with a built-in recovery period. Environ Res 73:52–62
   PubMedGoogle Scholar